杨燕光,蔡 晶,何晓军.三维适形放疗联合同步化疗治疗直肠癌术后复发[J].肿瘤学杂志,2012,18(5):349-352. |
三维适形放疗联合同步化疗治疗直肠癌术后复发 |
Clinical Observation of Concurrent Three-dimensional Conformal Radiotherapy and Chemotherapy in the Treatment for Rectal Cancer with Local Recurrence Postoperation |
投稿时间:2011-10-21 |
DOI: |
|
|
中文关键词: 直肠肿瘤 肿瘤复发 三维适形放疗 同步化疗 |
英文关键词:rectal neoplasms neoplasm recurrence three-dimensional conformal radiotherapy(3D-CRT) concurrent chemotherapy |
基金项目: |
|
摘要点击次数: 1815 |
全文下载次数: 921 |
中文摘要: |
摘 要:[目的] 探讨三维适形放疗同步化疗治疗直肠癌术后复发的疗效。[方法] 78例术后复发直肠癌患者分为适形放疗加化疗组(适形组)39例,常规放疗加化疗组(常规组)39例。观察并比较两组的临床疗效和不良反应的发生。[结果] 适形组和常规组1、2、3年生存率分别为89.7%、64.1%、46.2%和64.1%、35.9%、23.1%(P<0.05),中位生存期分别为35个月和20个月;3年肿瘤局部控制率分别为64.1%、41.0%(P<0.05);适形组放射性直肠炎、放射性膀胱炎和皮肤反应的发生率低于常规组(P<0.05)。[结论] 三维适形放射治疗联合FOLFOX方案同步化疗是治疗直肠癌术后复发的安全有效的方法,能明显地提高患者的远期生存率,减少放疗反应。 |
英文摘要: |
Abstract: [Purpose] To investigate the clinical efficacy of concurrent three-dimensional conformal radiotherapy and chemotherapy(3D-CRC) in the treatment for rectal cancer with local recurrence postoperation.[Methods] Seventy-eight rectal cancer patients with local recurrence postope-ration were divided into two groups: 3D-CRC group (39 cases) and conventional radiochemotherapy(RC) group (39 cases).The clinical efficacy and side effects were observed and compared. [Results] The 1-,2- and 3- year survival rates were 89.7%,64.1%,46.2% in 3D-CRC group,64.1%,35.9%,23.1% in RC group,with significant difference(P<0.05). The median survival time in the 2 groups was 35 months and 20 months respectively. The 3-year local control rate of 3D-CRC group and RC group were 64.1%and 41.0%,respectively (P<0.05). The incidences of radiation proctitis,radiocystitis and skin reaction were lower in 3D-CRC group than those in RC group(P<0.05). [Conclusion] Concurrent three-dimensional conformal radiotherapy and chemotherapy might be safe and effective in the treatment for rectal cancer with local recurrence postoperation,and may improve survival rate with less toxicity. |
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |